Special Topics

Bronchiectasis and COPD


  • Trials Show Promise for New Agents to Treat COPD

    Trials Show Promise for New Agents to Treat COPD

    Several trial results for the treatment of COPD were shared at the 2023 International Conference. Gerard J. Criner, MD, and David M. Mannino III, MD, discussed findings from the BOREAS trial, expectations from the ongoing NOTUS trial, and data from the ENHANCE-1 and ENHANCE-2 studies.

    Read More

  • Ongoing Trials, Genetic Breakthroughs Pave the Way for Progress in Bronchiectasis

    Ongoing Trials, Genetic Breakthroughs Pave the Way for Progress in Bronchiectasis

    Timothy R. Aksamit, MD, FCCP, and Mark Metersky, MD, FCCP, comment on updates from multiple studies making headway in treating bronchiectasis. These trials, presented at the ATS 2023 International Conference, reflect research focusing on the three pillars of the disease: infection, inflammation, and mucociliary milieu. The trials included phase three of PROMIS II and phase…

    Read More


Other Topics